Identifying Plasma Biomarkers of Liver Cirrhosis Progression and Decompensation Using Top-Down Proteomics
Year: 2025
Type: article
Abstract: Introduction: Cirrhosis affects 2-5 million Americans. While most have compensated cirrhosis, many decompensate and experience life-threatening complications, reducing life expectancy from 12 to less than 2 years. Identifying cirrhotic patients at high risk of decompensation is critical to optimize care and reduce morbidity and mortality. Non-invasive and reliable diagnostic tools are needed to identify and predict those at highest risk of disease progression.
Institution: Northwestern Memorial Hospital
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,300
OpenAlex ID: W4406152086